Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression

被引：0
|
作者：
Michelle Junyi He
Wenjun Pu
Xi Wang
Xiaoni Zhong
Dong Zhao
Zhipeng Zeng
Wanxia Cai
Jiayi Liu
Jianrong Huang
Donge Tang
Yong Dai
机构：
[1] The Second Clinical Medical College of Jinan University,Clinical Medical Research Center
[2] Shenzhen People’s Hospital,Department of Biology, Department of Brain and Cognitive Sciences
[3] Massachusetts Institute of Technology,The First Affiliated Hospital
[4] Jinan University,The First Affiliated Hospital (Shenzhen People’s Hospital)
[5] Southern University of Science and Technology,Department of Nephrology Center, Department of Liver Transplant Center, The Third People’s Hospital of Shenzhen
[6] The Second Affiliated Hospital of Southern University of Science and Technology,Guangxi Key Laboratory of Metabolic Disease Research
[7] Central Laboratory of Guilin,undefined
[8] 924St Hospital,undefined
来源：
Cancer Cell International | / 22卷
关键词：
Spatial metabolomics; Liver cirrhosis; Hepatocellular carcinoma; Disease progression; Amino acid metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF SUNITINIB IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
    Biolato, M.
    Strocchi, E.
    Mancinelli, M.
    Basso, M.
    Miele, L.
    Pompili, M.
    Rapaccini, G. L.
    Gasbarrini, A.
    Barone, C.
    Grieco, A.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E64 - E65
  • [42] REGULATION OF OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN LIVER CIRRHOSIS RESPONDENT
    Zaheer, Ayesha
    Ali, Shahid
    Nawaz, Hira
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (05): : 9968 - 9970
  • [43] Laparoscopic radiofrequency of hepatocellular carcinoma (HCC) in liver cirrhosis
    Montorsi, M
    Santambrogio, R
    Bianchi, P
    Opocher, E
    Tagliaferri, B
    Zuin, M
    Bertolini, E
    Podda, M
    HEPATO-GASTROENTEROLOGY, 2001, 48 (37) : 41 - 45
  • [44] Aberrant FHIT transcripts in hepatocellular carcinoma and liver cirrhosis
    Gramantieri, L
    Di Tomaso, M
    Bartolucci, B
    Brillanti, S
    Gaiani, S
    Masi, L
    Piscaglia, F
    Mazziotti, A
    Bolondi, L
    HEPATOLOGY, 1998, 28 (04) : 343A - 343A
  • [45] HFE gene mutations in liver cirrhosis and hepatocellular carcinoma
    Sebastiani, G
    Benvegnù, L
    Angeli, P
    Pontisso, P
    Gatta, A
    Alberti, A
    JOURNAL OF HEPATOLOGY, 2000, 32 : 154 - 154
  • [46] Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis
    Ezaki, T
    Yamamoto, K
    Yamaguchi, H
    Sasaki, Y
    Ishida, T
    Mori, M
    Aimitsu, S
    HEPATO-GASTROENTEROLOGY, 2002, 49 (47) : 1363 - 1368
  • [47] Sorafenib in unresectable hepatocellular carcinoma and advanced liver cirrhosis
    Pinter, M.
    Sieghart, W.
    Graziadei, I.
    Vogel, W.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S13 - S13
  • [48] Liver transplantation for hepatocellular carcinoma in cirrhosis: Prognostic parameters
    Benckert, C
    Jonas, S
    Thelen, A
    Spinelli, A
    Schumacher, G
    Heise, M
    Langrehr, J
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1693 - 1694
  • [49] Risk factors for hepatocellular carcinoma in patients with liver cirrhosis
    Rodríguez, MAM
    Unceta, PR
    Cabrera, MT
    Hernández, JMI
    Aguilar, FC
    García, FD
    Rodríguez, EB
    Rojas, AM
    Herrera, LM
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2000, 92 (07) : 464 - 469
  • [50] Progression to cirrhosis, hepatocellular carcinoma and liver- related mortality in chronic hepatitis B patients in Italy
    Ieluzzi, Donatella
    Covolo, Loredana
    Donato, Francesco
    Fattovich, Giovanna
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (05) : 427 - 432
12345